Next-Generation Sonogenic Stimulation for Neural Circuit Modulation

Publication ID: 24-11857809_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Sonogenic Stimulation for Neural Circuit Modulation,” Published Technical Disclosure No. 24-11857809_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857809_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,809.

Summary of the Inventive Concept

A system and method for modulating neural circuits using ultrasound, enabling targeted and spatially-precise control of neural activity, with potential applications in treating neurological disorders and enhancing cognitive function.

Background and Problem Solved

The original patent disclosed a method for altering neural activity using ultrasound, but had limitations in terms of spatial resolution and specificity. The new inventive concept addresses these limitations by introducing a micro-TRP4 expression vector for spatially-targeted expression of TRP4 polypeptides, enabling more precise control of neural activity.

Detailed Description of the Inventive Concept

The new inventive concept comprises a neural interface device, a micro-TRP4 expression vector, and an ultrasound transducer array. The micro-TRP4 expression vector is configured to express TRP4 polypeptides in a spatially-targeted manner within the neural circuit, allowing for precise control of neural activity. The ultrasound transducer array applies ultrasound energy to the targeted tissue portion, stimulating the TRP4-expressing neurons. The system can be used to modulate neural circuits, generate neural maps, and treat neurological disorders.

Novelty and Inventive Step

The new claims introduce the concept of spatially-targeted expression of TRP4 polypeptides using a micro-TRP4 expression vector, which is not disclosed in the original patent. This enables more precise control of neural activity and represents a significant advancement over the original invention.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different ultrasound frequencies, pulse durations, or spatial patterns to modulate neural activity. Additionally, the system could be adapted for use in other applications, such as neural prosthetics or brain-computer interfaces.

Potential Commercial Applications and Market

The inventive concept has potential applications in the treatment of neurological disorders, such as Parkinson's disease, epilepsy, and depression, as well as in enhancing cognitive function. The market for neural modulation technologies is rapidly growing, with an estimated value of $10 billion by 2025.

Field of Art

Neuroscience and biomedical engineering, with expertise in neural stimulation techniques, genetic engineering of neural circuits, and ultrasound-based cellular modulation

Person of Ordinary Skill (PHOSITA) Profile

A researcher with advanced training in neurobiology, genetic engineering, and biomedical instrumentation, capable of understanding complex neural stimulation techniques and genetic modification strategies

Obviousness Rationale

A person of ordinary skill would recognize that the PTD represents a predictable extension of the source patent's core ultrasound neural stimulation technique by introducing spatially-targeted genetic expression and expanded application domains. The fundamental mechanism of ultrasound-mediated neural modulation remains consistent, with the PTD simply refining the approach through more precise genetic targeting and novel application contexts. These variations represent logical incremental improvements that would be apparent to a skilled practitioner familiar with neural engineering and genetic manipulation techniques.

Obvious Combinations & Variations

Source Patent Element
Ultrasound-sensitive transmembrane protein (TRP-4) for neural stimulation
PTD Variation
Micro-TRP4 expression vector for spatially-targeted neural circuit modulation
Obviousness Reasoning
A PHOSITA would recognize that refining genetic expression strategies to enable more precise spatial targeting is a predictable optimization of the original neural stimulation technique
Source Patent Element
Ultrasound stimulation of neurons in mammalian subjects
PTD Variation
Neural mapping and cognitive function enhancement applications
Obviousness Reasoning
Expanding the application domain of ultrasound neural stimulation to diagnostic and cognitive enhancement contexts represents an obvious extension using known techniques
Source Patent Element
Genetic modification of neurons to express ultrasound-sensitive proteins
PTD Variation
Neural prosthetic device using TRP4-expressing neural interfaces
Obviousness Reasoning
Applying the core genetic modification technique to assistive technologies is a straightforward and predictable implementation for a skilled practitioner
Source Patent Element
Ultrasound transducer for neural stimulation
PTD Variation
Ultrasound transducer array with variable frequency and spatial modulation
Obviousness Reasoning
Modifying ultrasound delivery parameters represents a routine design optimization well within the capabilities of a person skilled in the art
Source Patent Element
Method of stimulating neurons using ultrasound
PTD Variation
Neurological disorder treatment through targeted neural circuit modulation
Obviousness Reasoning
Extending the neural stimulation technique to therapeutic applications is an obvious and predictable progression of the original invention
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in the Published Technical Disclosure render obvious the claimed subject matter of US Patent 11857809, as a person having ordinary skill in the art would recognize the disclosed techniques as predictable extensions of the source patent's core ultrasound neural stimulation methodology, involving routine optimization and application of known genetic and ultrasound-based neural modulation principles.

Original Patent Information

Patent NumberUS 11,857,809
TitleSonogenic stimulation of cells
Assignee(s)Salk Institute for Biological Studies